ALB and hereditary elliptocytosis: In addition, the extracorporeal albumin dialysis (ECAD) such as molecular adsorbents recirculating system (MARS) that directly reduce endogenous toxin in case of severe HE [27,28] is served as a bridging therapy for those planned for OLT.